Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
A Phase II Multi-Center, Randomized, Open-Label, Active-Control, Dose-Ranging Study of Interferon -2B Given Via Continuous Subcutaneous Infusion in Subjects with Hepatitis C Virus Genotype 1 Infection
Grant
Overview
Affiliation
Overview
Date/time Interval
August 24, 2009 - October 5, 2013
Awarded By
Duke University
Total Award Amount
29050.00
Direct Costs
23056.00
Sponsor Award Id
4316001
Affiliation
Contributor
Jenni Wise
Investigator